The Effect of Belantamab Mafodotin on Primary Myeloma-Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells.

Matula, Zsolt; Uher, Ferenc; Vályi-Nagy, István; Mikala, Gábor

Matula, Zsolt; Uher, Ferenc; Vályi-Nagy, István; Mikala, Gábor.

Afiliação

Matula Z; Laboratory for Experimental Cell Therapy, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, 1097 Budapest, Hungary.
Uher F; Laboratory for Experimental Cell Therapy, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, 1097 Budapest, Hungary.
Vályi-Nagy I; Department of Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, 1097 Budapest, Hungary.
Mikala G; Department of Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, 1097 Budapest, Hungary.

Int J Mol Sci ; 24(6)2023 Mar 10.

Article em En | MEDLINE | ID: mdl-36982377

Assuntos

Mieloma Múltiplo; Humanos; Mieloma Múltiplo/patologia; Antígeno de Maturação de Linfócitos B/metabolismo; Técnicas de Cocultura; Anticorpos Monoclonais Humanizados/uso terapêutico

Palavras-chave

belantamab mafodotin; bone marrow mesenchymal stromal cell; cancer drug resistance; mitochondrial transfer; multiple myeloma

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Hungria País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google